Novo Nordisk A/S (NVO) Given Average Rating of "Hold" by Brokerages

Doris Richards
January 13, 2018

Two analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company. Novo now has $132.28B valuation. About 461,890 shares traded. U.S. Bancorp (NYSE:USB) has risen 23.07% since January 11, 2017 and is uptrending. It has underperformed by 40.63% the S&P500. LINK's SI was 500 shares in January as released by FINRA. Its down 17.35% from 9.43 million shares previously. With 100 avg volume, 5 days are for Interlink Electronics Incorporated (NASDAQ:LINK)'s short sellers to cover LINK's short positions. The SI to Huntsman Corporation's float is 3.59%. The stock decreased 7.27% or $0.5 during the last trading session, reaching $6.35. About 2.03 million shares traded. The Mosaic Company (NYSE:MOS) has declined 7.87% since January 11, 2017 and is downtrending. It has outperformed by 6.37% the S&P500. Secor Advsr Limited Partnership owns 32,150 shares. Berry Global (NYSE:BERY) was reduced too.

Shares of Novo Nordisk A/S (NYSE:NVO) have received a consensus recommendation of "Hold" from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Therefore 47% are positive.

KCS Wealth Advisory acquired a new position in shares of Novo Nordisk A/S (NYSE:NVO) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm has "Neutral" rating by Citigroup given on Monday, October 31. The correct version of this piece of content can be read at https://www.truebluetribune.com/2018/01/12/novo-nordisk-a-ss-nvo-buy-rating-reiterated-at-deutsche-bank.html. On Friday, September 9 the stock rating was downgraded by JP Morgan to "Neutral". As per Tuesday, December 6, the company rating was upgraded by UBS. The rating was downgraded by Morgan Stanley to "Equal-Weight" on Thursday, September 1. The stock of Novo Nordisk A/S (NYSE:NVO) earned "Underperform" rating by Bank of America on Friday, October 28.


COPYRIGHT VIOLATION WARNING: "Novo Nordisk A/S (NVO) Given Average Rating of "Hold" by Brokerages" was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. The stock of Novo Nordisk A/S (NYSE:NVO) has "Conviction Buy" rating given on Monday, February 15 by Goldman Sachs.

Investors sentiment increased to 1.24 in Q3 2017. Its down 1.00, from 1 in 2017Q2. 67 funds opened positions while 169 raised stakes. Arrowmark Colorado Liability Com stated it has 14,472 shares. Agf Inc reported 42,354 shares stake. Van Hulzen Asset Mngmt Limited Liability Company reported 21,600 shares. Hudson Bay Management Lp invested in 0.58% or 376,000 shares. Fukoku Mutual Life reported 2,000 shares or 0.02% of all its holdings. Cambridge Investment Research Advsr holds 8,998 shares or 0% of its portfolio. Hsbc Hldg Public Limited holds 0.03% of its portfolio in The Mosaic Company (NYSE:MOS) for 806,653 shares. (NASDAQ:TMUS) or 14,900 shares. Natl Asset Incorporated invested in 0.04% or 11,300 shares. Royal Commercial Bank Of Canada, a Ontario - Canada-based fund reported 8,136 shares. NVO's profit will be $1.35 billion for 24.54 P/E if the $0.56 EPS becomes a reality. The firm operates in five divisions: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments and Additives. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, propylene oxide, polyols, propylene glycol, thermoplastic polyurethane, aniline, and methyl tertiary-butyl ether products. Zacks Investment Research raised Novo Nordisk A/S from a hold rating to a buy rating and set a $55.00 target price for the company in a research note on Wednesday, September 13th. Therefore 27% are positive. The rating was maintained by Liberum Capital on Friday, August 7 with "Hold". RBC Capital Markets has "Outperform" rating and $30 target. The firm earned "Buy" rating on Tuesday, December 6 by UBS. The firm has "Hold" rating given on Friday, October 27 by Mizuho. As per Tuesday, September 5, the company rating was maintained by Robert W. Baird. As per Wednesday, December 13, the company rating was upgraded by J.P. Morgan. The stock has a market capitalization of $107,480.00, a price-to-earnings ratio of 22.02, a price-to-earnings-growth ratio of 3.06 and a beta of 0.66.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER